Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 26,736 followers.

New article: Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor-resistant pancreatic ductal adenocarcinoma https://t.co/X8bheiCrUf #pancreaticcancer #oncology https://t.co/SP0Iknirmh

19 Aug 2022

Reply Repost Favourite

RT @FrontOncology: New research: Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenoca…

12 Aug 2022

Reply Repost Favourite

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma: Metabolic reprogramming, due in part to the overexpression of metabolic enzymes, is a key hallmark of cancer cells. #oncology… https://t.co/

03 Aug 2022

Reply Repost Favourite

New research: Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma: Metabolic reprogramming, due in part to the overexpression of metabolic enzymes, is a key hallmark of cancer cells.… https://t.

03 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.